Suchen
Smith & Nephew PLC
SNNZur Watchlist hinzufügen
29.945USD
-0.115-0.38%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
13.09BMarktkapitalisierung
26.64KGV TTM
mehr Informationen über Smith & Nephew PLC Unternehmen
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Smith & Nephew PLC Informationen
BörsenkürzelSNN
Name des UnternehmensSmith & Nephew PLC
IPO-datumSep 18, 2087
CEONath (Deepak S)
Anzahl der mitarbeiter17349
WertpapierartDepository Receipt
GeschäftsjahresendeSep 18
AddresseBuilding 5
StadtWATFORD
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited Kingdom
PostleitzahlWD18 8YE
Telefon4401923477100
Websitehttps://www.smith-nephew.com/
BörsenkürzelSNN
IPO-datumSep 18, 2087
CEONath (Deepak S)
Führungskräfte von Smith & Nephew PLC
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+1.06%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.35K
+1.07%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+22.23%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.27K
+0.94%
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
1.14K
+2.55%
Mr. Craig Gaffin
Mr. Craig Gaffin
President - Orthopaedics
President - Orthopaedics
894.00
+2.57%
Ms. Elga Lohler
Ms. Elga Lohler
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+1.06%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.35K
+1.07%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+22.23%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Sports Medicine Joint Repair
1.07B
17.31%
Knee Implants
1.01B
16.40%
Advanced Wound Care
766.00M
12.43%
Trauma & Extremities
649.00M
10.53%
Arthroscopic Enabling Technologies
647.00M
10.50%
Andere
2.02B
32.84%
Nach RegionUSD
Name
Umsatz
Anteil
United States of America
3.31B
53.63%
Other Established Markets
1.48B
24.03%
Emerging &internatiuonal market
1.00B
16.27%
United Kingdom
246.00M
3.99%
China
128.00M
2.08%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Sports Medicine Joint Repair
1.07B
17.31%
Knee Implants
1.01B
16.40%
Advanced Wound Care
766.00M
12.43%
Trauma & Extremities
649.00M
10.53%
Arthroscopic Enabling Technologies
647.00M
10.50%
Andere
2.02B
32.84%
Aktionärsstatistik
Aktualisiert: Thu, Apr 16
Aktualisiert: Thu, Apr 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
River Road Asset Management, LLC
0.76%
BMO Capital Markets (US)
0.74%
BofA Global Research (US)
0.29%
Brandes Investment Partners, L.P.
0.28%
Goldman Sachs Asset Management, L.P.
0.25%
Andere
97.68%
Aktionäre
Aktionäre
Anteil
River Road Asset Management, LLC
0.76%
BMO Capital Markets (US)
0.74%
BofA Global Research (US)
0.29%
Brandes Investment Partners, L.P.
0.28%
Goldman Sachs Asset Management, L.P.
0.25%
Andere
97.68%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
2.88%
Research Firm
1.96%
Investment Advisor/Hedge Fund
1.81%
Hedge Fund
0.32%
Pension Fund
0.26%
Family Office
0.17%
Family Office
0.17%
Family Office
0.12%
Venture Capital
0.01%
Andere
92.31%
Institutionelle Beteiligung
Aktualisiert: Sun, Apr 5
Aktualisiert: Sun, Apr 5
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
471
30.95M
7.25%
-11.49M
2025Q4
454
32.27M
7.59%
-10.26M
2025Q3
458
32.77M
7.72%
-12.10M
2025Q2
468
34.86M
7.96%
-12.17M
2025Q1
470
32.31M
7.38%
-15.13M
2024Q4
454
34.98M
8.00%
-9.87M
2024Q3
442
33.73M
7.72%
-17.08M
2024Q2
451
37.69M
8.62%
-9.14M
2024Q1
460
34.95M
7.99%
-8.57M
2023Q4
456
32.65M
7.47%
-10.09M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
River Road Asset Management, LLC
3.17M
0.75%
+384.93K
+13.82%
Dec 31, 2025
BMO Capital Markets (US)
3.17M
0.74%
-68.29K
-2.11%
Dec 31, 2025
BofA Global Research (US)
1.24M
0.29%
+374.04K
+43.38%
Dec 31, 2025
Brandes Investment Partners, L.P.
1.18M
0.28%
-69.01K
-5.52%
Dec 31, 2025
Goldman Sachs Asset Management, L.P.
1.06M
0.25%
-29.55K
-2.71%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
728.67K
0.17%
+236.64K
+48.10%
Dec 31, 2025
Parametric Portfolio Associates LLC
980.17K
0.23%
-35.11K
-3.46%
Dec 31, 2025
Todd Asset Management LLC
944.58K
0.22%
+219.35K
+30.25%
Dec 31, 2025
BNP Paribas Securities Corp. North America
928.24K
0.22%
-9.70K
-1.03%
Dec 31, 2025
Kentucky Teachers' Retirement System
599.50K
0.14%
+144.80K
+31.85%
Dec 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Brandes International ETF
1.07%
ALPS Disruptive Technologies ETF
0.93%
ActivePassive International Equity ETF
0.2%
Avantis Responsible International Equity ETF
0.12%
SP Funds S&P World (ex-US) ETF
0.11%
Avantis International Equity ETF
0.07%
DFA Dimensional International Core Equity 2 ETF
0.04%
State Street SPDR S&P Kensho New Econ Comp ETF
0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
0.01%
SGI Enhanced Global Income ETF
0%
Brandes International ETF
Anteil1.07%
ALPS Disruptive Technologies ETF
Anteil0.93%
ActivePassive International Equity ETF
Anteil0.2%
Avantis Responsible International Equity ETF
Anteil0.12%
SP Funds S&P World (ex-US) ETF
Anteil0.11%
Avantis International Equity ETF
Anteil0.07%
DFA Dimensional International Core Equity 2 ETF
Anteil0.04%
State Street SPDR S&P Kensho New Econ Comp ETF
Anteil0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
Anteil0.01%
SGI Enhanced Global Income ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
1.31B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Mar 05, 2026
SNN.NB Interim Cash Dividend of gross USD 0.482 paid on May 27, 2026 going ex on Mar 27, 2026
Mar 27, 2026
May 27, 2026
Mar 27, 2026
Aug 05, 2025
SNN.NB Final Cash Dividend of gross USD 0.3 paid on Nov 07, 2025 going ex on Oct 03, 2025
Oct 03, 2025
Nov 07, 2025
Oct 03, 2025
Feb 26, 2025
SNN.NB Approximate interim Cash Dividend of gross USD 0.462 paid on May 28, 2025 going ex on Mar 28, 2025
Mar 28, 2025
May 28, 2025
Mar 28, 2025
Sep 24, 2024
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 08, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Nov 08, 2024
Oct 04, 2024
Mar 04, 2024
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 22, 2024 going ex on Apr 01, 2024
Apr 02, 2024
May 22, 2024
Apr 01, 2024
Aug 03, 2023
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 01, 2023 going ex on Oct 05, 2023
Oct 06, 2023
Nov 01, 2023
Oct 05, 2023
Feb 27, 2023
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 17, 2023 going ex on Mar 30, 2023
Mar 31, 2023
May 17, 2023
Mar 30, 2023
Jul 29, 2022
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 26, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 26, 2022
Sep 29, 2022
Mar 14, 2022
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 11, 2022 going ex on Mar 31, 2022
Apr 01, 2022
May 11, 2022
Mar 31, 2022
Aug 12, 2021
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 27, 2021 going ex on Sep 30, 2021
Oct 01, 2021
Oct 27, 2021
Sep 30, 2021
Mehr Anzeigen
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
